Specifically for multiple sclerosis (Dendrou et al. 2015), there is independent evidence for elevated lipid peroxidation and breakdown products thereof in plasma and CSF of patients (Ferretti and Bacchetti 2011; Gonzalo et al. 2012; Miller et al. 2011), warranting the investigation of MDA and its impact on the antigenicity of established MS autoantigens such as myelin oligodendrocyte glycoprotein (MOG). The gene discussed is MOG; the disease is myeloid sarcoma.